NCT02688361 - A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

April 13, 2016

Study Completion Date

April 13, 2016

Conditions

Infections, Respiratory Tract

Interventions

DRUG

Fluimucil® 2% solution

Participants will be orally administered with 10ml of 2% oral solution of Fluimucil® (reference).

DRUG

Acetylcysteine 2% solution

Participants will be orally administered with 10ml of 2% oral solution of Acetylcysteine (test)

Trial Locations (1)

GSK Investigational Site, Erfurt